title: Biochemical characterization of flestolol esterase.
abstract: The blood esterase that mediates the metabolism of flestolol, an ultra short-acting beta blocker, was characterized. Esterase activity occurred in plasma of human, dog, rat, and guinea pig and not in erythrocytes of the same species. The esterase activity was greatest in humans and guinea pigs followed by dogs and rats. Purified human serum cholinesterase was very active against flestolol while human serum albumin was slightly active. Human and bovine erythrocyte membrane acetylcholinesterases, electric eel acetylcholinesterase, human hemoglobin, dog, rat, chicken, and bovine serum albumin were all inactive. Esterase activity with flestolol was inhibited in human, dog, and rat blood by echothiophate, eserine, and sodium fluoride. Guinea pig blood esterase activity was inhibited by echothiophate and sodium fluoride, but not by eserine. Metabolic interaction studies indicated that succinylcholine, procaine, and chloroprocaine interfere with the metabolism of flestolol in human blood. Succinylcholine prolonged the in vitro half-life of flestolol in dog blood, but acetylcholine, procaine, and chloroprocaine had no effect. Flestolol did not affect the metabolism of procaine or chloroprocaine in human and dog blood. The metabolism rate of flestolol decreased in individuals with atypical, fluoride-resistant and silent forms of serum cholinesterase.
authors.affiliation: Du Pont Merck Pharmaceutical Company, Drug Metabolism and Pharmacokinetics Section, Stine-Haskell Research Center, Newark, DE 19714.
authors.forename: C Y
authors.initials: CY
authors.lastname: Quon
authors.forename: H F
authors.initials: HF
authors.lastname: Stampfli
mesh_terms: D000818:Animals; D002265:Carboxylic Ester Hydrolases / Q000097:blood* / Q000378:metabolism* / Q000493:pharmacokinetics; D004285:Dogs; D004347:Drug Interactions; D004950:Esterases / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D006168:Guinea Pigs; D006207:Half-Life; D006801:Humans; D006868:Hydrolysis; D011343:Procaine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D051381:Rats; D013045:Species Specificity; D013390:Succinylcholine / Q000494:pharmacology
chemical_list: D011343:Procaine; C004616:chloroprocaine; D004950:Esterases; D002265:Carboxylic Ester Hydrolases; C084148:flestolol esterase; D013390:Succinylcholine